Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer

Condition:   Neoplasms Intervention:   Drug: VIP236 Sponsor:   Vincerx Pharma, Inc. Recruiting

Source: ClinicalTrials.gov - February 6, 2023 Category: Research Source Type: clinical trials